Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Labeling DNA Probes03:31

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence applications in surgical education and training: a systematic review.

Frontiers in artificial intelligence·2026
Same author

Supramolecular Structural Variations in iPP/ZnO Nanocomposites: Effect on Optical and Dielectric Performance.

ACS omega·2026
Same author

Microencapsulated <i>Vaccinium floribundum</i> Kunth extract promotes endothelial angiogenesis <i>in vitro</i> and attenuates inflammation <i>in vitro</i> and <i>in vivo</i>.

Frontiers in veterinary science·2026
Same author

Carbon-based nanomaterials in biomedicine and technology.

Frontiers in chemistry·2026
Same author

Synergetic effects of silicon nanoparticles and multi-walled carbon nanotubes on the structural and dielectric properties of polystyrene-based nanocomposites.

Frontiers in chemistry·2026
Same author

Modeling an SPR Sensor for Carcinoma-Related Refractive-Index Detection: The Case of CaF<sub>2</sub>/Au/Si<sub>3</sub>N<sub>4</sub>/BP Multilayer System.

Biosensors·2026

Related Experiment Video

Updated: Jul 5, 2026

Graphene Coatings for Biomedical Implants
13:21

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

21.8K

SPR biosensor with a graphene overlayer for carcinoma detection.

Talia Tene1, Katherine Tixi Gallegos2, María José Mendoza Salazar3

  • 1Department of Chemistry, Universidad Técnica Particular de Loja, Loja, Ecuador.

Frontiers in Bioengineering and Biotechnology
|March 11, 2026
PubMed
Summary

This study introduces a novel multilayer surface plasmon resonance (SPR) biosensor for early carcinoma detection. The CaF2/Cu/TiO2/Graphene design shows high sensitivity and accuracy for detecting cancer biomarkers.

Keywords:
SPRbiosensorcarcinomacoppergraphenesensitivitytitanium dioxide

More Related Videos

Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
07:51

Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection

Published on: February 1, 2022

3.9K
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.8K

Related Experiment Videos

Last Updated: Jul 5, 2026

Graphene Coatings for Biomedical Implants
13:21

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

21.8K
Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
07:51

Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection

Published on: February 1, 2022

3.9K
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.8K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Early carcinoma detection is crucial for effective treatment and improved patient outcomes.
  • Label-free, high-sensitivity biosensors are needed for sensitive and accurate cancer biomarker detection.
  • Surface Plasmon Resonance (SPR) biosensors offer promising label-free detection capabilities.

Purpose of the Study:

  • To computationally evaluate multilayer SPR architectures for enhanced sensitivity and accuracy in carcinoma detection.
  • To investigate the performance of a CaF2/Cu/TiO2/Graphene multilayer SPR biosensor.
  • To assess the potential of this biosensor for cost-effective and sensitive cancer biomarker detection.

Main Methods:

  • Utilized the transfer-matrix method for computational evaluation of SPR architectures at 633 nm.
  • Analyzed reflectance, resonance-angle shifts, and near-field profiles for CaF2/Cu/TiO2/Graphene multilayer stacks.
  • Derived key performance metrics including sensitivity, detection accuracy (DA), figure of merit, and limit of detection (LOD) across a concentration range of 1-5 ng/mL.

Main Results:

  • The CaF2/Cu/TiO2/Graphene multilayer SPR biosensor demonstrated superior performance.
  • Achieved a high sensitivity of 481.29°/RIU and a detection accuracy (DA) of 0.80.
  • Exhibited pronounced evanescent-field confinement at the sensing interface, outperforming TiO2-only and Cu-only configurations.

Conclusions:

  • The developed CaF2/Cu/TiO2/Graphene SPR biosensor platform shows significant potential for sensitive and cost-effective carcinoma biomarker detection.
  • The integration of graphene enhances the performance of SPR biosensors for early cancer diagnosis.
  • The findings support the experimental realization of this advanced biosensing technology for clinical applications.